Literature DB >> 16170397

TNF-alpha in the development of insulin resistance and other disorders in metabolic syndrome.

Simona Gwozdziewiczová1, Radka Lichnovská, Rabha Ben Yahia, Rudolf Chlup, Jirí Hrebícek.   

Abstract

Insulin resistance and obesity are very frequent disorders and are described as the dominant risk factors for cardiovascular disease. The aim of this study was to analyze the interrelations between several metabolic variables (including TNF-alpha) and factors related to insulin resistance in groups of both normal and hyperlipidemic postmenopausal women and men of appropriate age, and to attempt to elucidate the gender differences. The study was carried out on 70 out-patients of the Metabolic Center. From these, 40 patients (20 men and 20 women) were selected with mild hyperlipidemia. Two other groups (10 men and 20 women) with approximately normal serum lipids parameters were taken as "controls". In hyperlipidemic women the mean serum concentration of the TNF-alpha was no different from that in the control group in spite of the fact that values of HOMA IR, insulin, proinsulin and lipid parameters increased significantly. In hyperlipidemic men we have found the decrease in TNF-alpha in comparison with the control group. In all four groups the statistical analysis showed correlations between metabolic parameters (including TNF-alpha) and parameters related to insulin resistance. Also differences in relation to the gender have been found. Multiple regression analysis demonstrated the important role of TNF-alpha in the regulation of both the insulin resistance and in the secretion of insulin in women. In men, BMI and HDL-cholesterol played a dominant role, while the role of TNF-alpha seemed to be minimal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170397

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  10 in total

1.  CD11c(+) macrophages and levels of TNF-α and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidaemia.

Authors:  K Uchida; M Satoh; G Inoue; K Onuma; M Miyagi; K Iwabuchi; M Takaso
Journal:  Clin Exp Immunol       Date:  2015-04-20       Impact factor: 4.330

2.  Establishment of a cut-point value of serum TNF-alpha levels in the metabolic syndrome.

Authors:  Carmen M Gurrola-Díaz; Sergio Sánchez-Enriquez; Edith Oregon-Romero; Pedro M García-López; Pedro Garzón de la Mora; Blanca E Bastidas-Ramírez; Mercedes González-Hita; José F Muñoz-Valle
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats.

Authors:  Ying Qin; Ya-ping Tian
Journal:  Lipids Health Dis       Date:  2010-07-26       Impact factor: 3.876

4.  Cytokine- and interferon-modulating properties of Echinacea spp. root tinctures stored at -20 degrees C for 2 years.

Authors:  Dustin A McCann; Avery Solco; Yi Liu; Filippo Macaluso; Patricia A Murphy; Marian L Kohut; David S Senchina
Journal:  J Interferon Cytokine Res       Date:  2007-05       Impact factor: 2.607

5.  Association of Insulin Resistance with Serum Interleukin-6 and TNF-α Levels During Normal Pregnancy.

Authors:  Abdolreza Sotoodeh Jahromi; Parvin Zareian; Abdolhossein Madani
Journal:  Biomark Insights       Date:  2011-01-12

6.  Association of TNF-α with insulin resistance in type 2 diabetes mellitus.

Authors:  Jatla Jyothi Swaroop; Duggirala Rajarajeswari; J N Naidu
Journal:  Indian J Med Res       Date:  2012       Impact factor: 2.375

7.  A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.

Authors:  Shannon M Reilly; Maryam Ahmadian; Brian F Zamarron; Louise Chang; Maeran Uhm; BreAnne Poirier; Xiaoling Peng; Danielle M Krause; Evgenia Korytnaya; Adam Neidert; Christopher Liddle; Ruth T Yu; Carey N Lumeng; Elif A Oral; Michael Downes; Ronald M Evans; Alan R Saltiel
Journal:  Nat Commun       Date:  2015-01-12       Impact factor: 14.919

8.  Effects of Adalimumab, an Anti-tumour Necrosis Factor-Alpha (TNF-α) Antibody, on Obese Diabetic Rats.

Authors:  Halima Ali Shuwa; Muhammad Kabiru Dallatu; Muhammed Haruna Yeldu; Hamidu Marafa Ahmed; Idris Abdullahi Nasir
Journal:  Malays J Med Sci       Date:  2018-08-30

Review 9.  Adipokines and hepatic insulin resistance.

Authors:  Yu Li; Lin Ding; Waseem Hassan; Daoud Abdelkader; Jing Shang
Journal:  J Diabetes Res       Date:  2013-05-16       Impact factor: 4.011

Review 10.  The Gut Microbiota and Inflammation: An Overview.

Authors:  Zahraa Al Bander; Marloes Dekker Nitert; Aya Mousa; Negar Naderpoor
Journal:  Int J Environ Res Public Health       Date:  2020-10-19       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.